Abeona Therapeutics Appoints Carsten Thiel...Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, today announced the appointment of … more ➔
Rentschler appoints Dr. Thomas RöschRentschler Biopharma SE announced today that Dr. Thomas Rösch will join the Company as Vice President Biopharma Engineering & Technology, effective April 1, 2018. He will be responsible for advanced … more ➔
Søren Tulstrup appointed CEO of Hansa Med...Hansa Medical AB, a biopharmaceutical company developing novel immunomodulatory enzymes, today announced that the board of directors have appointed Søren Tulstrup as new President and CEO of Hansa Medical … more ➔
Domainex appoints Dr Bodo SporiDomainex Ltd, a privately-owned drug discovery services company, has announced the appointment of Dr Bodo Spori as Head of Business Development for Europ. more ➔
SP Industries Announces Brian Larkin as Pr...SP Industries Inc. has announced the appointment of Brian Larkin as its President and Chief Executive Officer effective February 19th, replacing William (Bill) Downs who recently retired. more ➔
David Colpman joins Forendo Pharma’s...Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, today announces the appointment of David Colpman as a non-executive director to its Board of Directors. more ➔
Parexel Appoints Jamie Macdonald as CEOCompany Co-founder Josef von Rickenbach to retire after 35 years of leadership; serve as Chairman of the Board. more ➔
Radek píek to become new CEO of SOTIOSOTIO, a biotechnology company belonging to the PPF Group, announces today the appointment of Professor Radek píek as Chief Executive Officer. more ➔
Mission Therapeutics promotes Paul Thompso...Today Mission Therapeutics, a drug discovery and development company focused on treating fibrosis, neurodegenerative and other diseases by selectively targeting deubiquitylating enzymes (DUBs), announced … more ➔
Rentschler Biopharma appoints Federico Pol...Rentschler Biopharma SE, a service provider for biopharmaceuticals, today announced the appointment of Mr. Federico Pollano as the new Senior Vice President of Business Development, effective March … more ➔